Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia (Q36671633)
Jump to navigation
Jump to search
scientific article published on November 17, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia |
scientific article published on November 17, 2003 |
Statements
1 reference
Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia (English)
1 reference
Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia (English)
1 reference
1 reference
S. G. O'Brien
P. Meinhardt
E. Bond
J. Beck
B. Peng
C. Dutreix
G. Mehring
S. Milosavljev
C. Huber
R. Capdeville
1 November 2003
1 reference
1 reference
1 reference
1855-1859
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference